Platelet Rich Plasma (PRP) One-Shot Injection For Supraspinatus Tendinosis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

48 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-01-01

Study Completion Date

2021-04-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

It was conducted a prospective study with a series of 50 patients treated with PRP one-shot injection in patient affected by Supraspinatus Tendinosis. One independent observer performed clinical and functional evaluations at T0 (recruitment), T1 (one month after the injection), T2 (three months after the last injection) and T3 (six months after the last injection).

Constant Score, The Disabilites of the Arm,Shoulder and Hand Score (DASH) And Visual Analogue Scale (VAS) were administered at each evaluation.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Impact of Autologous Pure Platelet-rich Plasma in the Treatment of Tendon Disease

NCT03300531

Rotator Cuff Tear Lateral Epicondylitis Achilles Tendinitis

UNKNOWN PHASE2

Platelet Rich Plasma and Supraspinatus Tear

NCT03942679

Supraspinatus Tear

COMPLETED NA

Effect of PRP vs Corticosteroid in Rotator Cuff Tendinopathy Subtypes in Arthroscopic Repair

NCT05603468

Tendinopathy

RECRUITING PHASE4

In Vivo Clinical and Radiological Effects of Platelet-rich Plasma on Interstitial Supraspinatus Lesion: Randomized Study

NCT02672085

Supraspinatis Interstitial Partial-thickness Tears Platelet-rich Plasma (PRP)

UNKNOWN NA

Subacromial Injection of Allogeneic Platelet Rich Plasma (PRP) for Shoulder Impingement Syndrome

NCT02019537

Shoulder Impingement Syndrome

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Supraspinatus Tendinitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

patients treated by one-shot PRP injection

one-shot PRP injection

Intervention Type PROCEDURE

A single injection of PRP (7% concentrate) ml 4 was made in the Supraspinatus tendon and in the Subacromial space under ultrasound guidance.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

one-shot PRP injection

A single injection of PRP (7% concentrate) ml 4 was made in the Supraspinatus tendon and in the Subacromial space under ultrasound guidance.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age \> 18 years old;
* Supraspinatus tendinosis detected by MRI.

Exclusion Criteria

* Supraspinatus rupture;
* Previous shoulder surgery;
* Rotator cuff tears secondary to fracture;
* Hemoglobin \<7 g/dL or Platelets \< 30,000 microL;
* Active infection;
* Pregnant patients;
* Patients with hematologic and oncologic diseases.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No